Clinical Trial Update: Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator [Phase 4]

View source ↗

Summary

Phase 4 trial extension allowing access to imatinib for patients currently on imatinib in a Novartis-sponsored study who are judged by investigators to be benef…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Gastrointestinal Stromal Tumor

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: GIST and CML | Phase 4 | Status: ACTIVE_NOT_RECRUITING